Completed NA INTERVENTIONAL 2-arm NCT04941001

Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS) (OASIS)

Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS) in Primary Care Using a Digital Consultation Tool During the COVID-19 Pandemic

Sponsor: AstraZeneca

Conditions Asthma Asthma Attack Asthma Persistent Covid19

Interventions ReferID

Updated 6 times since 2021 Last updated: Aug 25, 2023 Started: Aug 9, 2021 Primary completion: Feb 1, 2023 Completion: Feb 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Asthma and Asthma Attack, this trial is completed. The trial is conducted by AstraZeneca and has accumulated 6 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2023 — Jul 2024 [monthly]

Completed NA
Aug 2023 — Sep 2023 [monthly]

Completed NA

Status: Recruiting → Completed
Feb 2022 — Aug 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Sep 2021 — Feb 2022 [monthly]

Not Yet Recruiting NA

First recorded

Aug 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca
Guy's and St Thomas' NHS Foundation Trust
King's College London

Data source: Guy's and St Thomas' NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom